WFDC2 and ovarian benign neoplasm: The results of the present study are consistent with those of Moore et al (13) who detected the levels of serum HE4 in epithelial ovarian cancer (129 cases) and benign ovarian tumor patients (352 cases) and observed that HE4 was significantly increased in the epithelial ovarian cancer patients.